Together, our results suggest that D2R signaling and its interactions with the Wnt/β-catenin pathway may play critical roles in modulating the extent of renal injury and that modifying D2R expression may serve as a novel therapeutic avenue for preventing the progression of kidney disease. This evidence concerns the gene DRD2 and kidney disorder.